Advertisement

Topics

Medivir out-licenses hepatitis C candidate in China

07:57 EDT 18 Aug 2017 | thePharmaLetter

Swedish drugmaker Medivir said today that it has licensed the exclusive rights for China to develop,…

Original Article: Medivir out-licenses hepatitis C candidate in China

NEXT ARTICLE

More From BioPortfolio on "Medivir out-licenses hepatitis C candidate in China"

Advertisement
Quick Search
Advertisement
Advertisement